Elan Seeks Frovelan Partner, More Sales Reps For Migraine Product Launch

Elan expects to launch the migraine therapy Frovelan this year with a co-promotion partner, VP-Investor Relations John Howarth indicated March 27 at the Banc of America Securities Healthcare Conference in Las Vegas.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet